We provide you with 20 years of free, institutional-grade data for CLDX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CLDX. Explore the full financial landscape of CLDX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$18,466
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Jimenez Freddy A. | Sale | -771 | $23.95 | $18,467 | 2025-08-15 |
| Marucci Anthony S | Open Market Purchase | 11,500 | $26.82 | 2024-11-12 | |
| Martin Samuel Bates | Sale | -17,172 | $35.42 | $608,315 | 2024-06-18 |
| Martin Samuel Bates | Derivatives Exercise | 20,169 | 2024-06-18 | ||
| Crowley Elizabeth | Sale | -30,000 | $34.87 | $1,045,962 | 2024-06-18 |
| Crowley Elizabeth | Derivatives Exercise | 30,000 | 2024-06-18 | ||
| Young Diane C. | Derivatives Exercise | 15,000 | 2024-06-13 | ||
| Crowley Elizabeth | Sale | -15,000 | $35.06 | $525,873 | 2024-06-11 |
| Crowley Elizabeth | Derivatives Exercise | 15,000 | 2024-06-11 | ||
| Young Diane C. | Sale | -45,000 | $35.26 | $1,586,844 | 2024-06-11 |
| Jimenez Freddy A. | Derivatives Exercise | 9,540 | 2024-06-07 | ||
| Heath-Chiozzi Margo | Sale | -58,369 | $33.65 | $1,964,088 | 2024-06-05 |
| Heath-Chiozzi Margo | Derivatives Exercise | 64,658 | 2024-06-05 | ||
| Jimenez Freddy A. | Sale | -8,006 | $33.6 | $269,002 | 2024-06-05 |
| Jimenez Freddy A. | Derivatives Exercise | 8,006 | 2024-06-05 | ||
| Wright Richard M. | Sale | -46,844 | $33.53 | $1,570,511 | 2024-06-05 |
| Wright Richard M. | Derivatives Exercise | 67,469 | 2024-06-05 | ||
| Martin Samuel Bates | Sale | -35,000 | $34.05 | $1,191,775 | 2024-06-03 |
| Martin Samuel Bates | Derivatives Exercise | 25,000 | 2024-06-03 | ||
| Heath-Chiozzi Margo | Sale | -38,719 | $34.07 | $1,319,156 | 2024-06-03 |
| Heath-Chiozzi Margo | Derivatives Exercise | 33,719 | 2024-06-03 | ||
| Cavanaugh Sarah | Sale | -20,853 | $33.73 | $703,334 | 2024-06-03 |
| Cavanaugh Sarah | Derivatives Exercise | 20,853 | 2024-06-03 | ||
| Crowley Elizabeth | Sale | -38,597 | $33.64 | $1,298,384 | 2024-06-03 |
| Crowley Elizabeth | Derivatives Exercise | 42,945 | 2024-06-03 | ||
| Jimenez Freddy A. | Derivatives Exercise | 24,166 | 2024-02-15 | ||
| Martin Samuel Bates | Derivatives Exercise | 10,750 | 2024-01-04 | ||
| KELER TIBOR | Sale | -16,860 | $36.93 | $622,611 | 2022-12-09 |
| KELER TIBOR | Derivatives Exercise | 16,860 | 2022-12-09 | ||
| Cavanaugh Sarah | Sale | -32,667 | $36.73 | $1,199,996 | 2022-08-19 |
| Cavanaugh Sarah | Derivatives Exercise | 32,667 | 2022-08-19 | ||
| Young Diane C. | Sale | -19,000 | $37.3 | $708,715 | 2022-08-19 |
| Young Diane C. | Derivatives Exercise | 64,000 | 2022-08-19 | ||
| Marucci Anthony S | Sale | -120,000 | $37.66 | $4,519,572 | 2022-08-17 |
| Marucci Anthony S | Derivatives Exercise | 120,000 | 2022-08-17 | ||
| Wright Richard M. | Sale | -15,328 | $37.71 | $578,048 | 2022-08-17 |
| Wright Richard M. | Derivatives Exercise | 15,328 | 2022-08-17 | ||
| Martin Samuel Bates | Sale | -20,000 | $37.04 | $740,778 | 2022-08-15 |
| Martin Samuel Bates | Derivatives Exercise | 20,000 | 2022-08-15 |
The information provided in this report about CLDX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Celldex Therapeutics, Inc(NASDAQ:CLDX) 
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The...
Website: http://www.celldex.com
Founded: 1983
Full Time Employees: 127
Sector: Healthcare
Industry: Biotechnology